video-poster
Are your procesess and equipment fully traceable? Learn About Chain of Compliance™

When you need confidence in your cold chain… Trust Cryoport

Request a Quote

The Latest From Our Blog View All

Growing with Our Clients: New Cryoport Innovations Help Support Commercial Gene Therapies and Nearly 400 Clinical Trials

We’re proud to provide global support for the first-ever commercial CART-T therapies, produced by our clients Kite (Gilead) and Novartis, as well as bluebird bio’s recently approved gene therapy. We're equally proud to support more than 380 clinical trials in the regenerative medicine field across the globe. 

With More Than 200 Cell and Gene INDs on File with FDA by 2020, Challenges Lie Ahead on Path to Approval

 “By 2025, we predict that the FDA will be approving 10 to 20 cell and gene therapy products a year based on an assessment of the current pipeline and the clinical success rates of these products.” – Scott Gottlieb, Former FDA Commissioner